BUND FINANCE › Stocks › MDLN
Medline Inc. (MDLN)
NASDAQ · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +10.65% above its 50-day average.
- It is -0.38% below its 200-day average (long-term downtrend).
- It sits at 40% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | US$21.4B | US$23.2B | US$25.5B | US$28.4B |
| Net income | −US$25.0M | US$234.0M | US$1.2B | US$1.2B |
| EPS (diluted) | -0.03 | 0.30 | 1.52 | 1.43 |
| Gross margin | 21.3% | 22.5% | 24.7% | 26.4% |
| Operating margin | 4.1% | 5.4% | 8.4% | 7.8% |
| Net margin | -0.1% | 1.0% | 4.7% | 4.1% |
| Free cash flow | −US$67.0M | US$1.4B | US$1.4B | US$1.3B |
| Total debt | — | US$16.8B | US$16.9B | US$12.6B |
| Cash | — | US$1.6B | US$250.0M | US$1.9B |
Compound annual growth: revenue 9.9% · net income — (3 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 65.3x | 64.3x | 27.1x |
| EV / EBITDA | 16.6x | 18.3x | 16.5x |
| Operating margin | 5.7% | — | 3.6% |
| Net margin | 1.8% | — | -0.0% |
| Debt / equity | 1.76 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination glov…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice